Safis Biotech

Safis Biotech is a biotechnology company specializing in the development of cost-effective recombinant proteins for bone regeneration and orthopedic applications. The company's core technology is a proprietary yeast-based expression system used to produce recombinant human Bone Morphogenetic Protein-2 (rhBMP-2), which is traditionally manufactured using more expensive mammalian cell cultures. Safis Biotech aims to provide high-quality, affordable growth factors for use in spinal fusions, fracture repairs, and dental procedures. By leveraging its unique production platform, the company seeks to improve patient access to advanced regenerative therapies while maintaining high biological activity and safety standards. Their lead candidate, Safis-BMP-2, is designed to offer a more scalable and economical alternative to existing bone graft substitutes.